HIV-1 Tat Protein Decreases Dopamine Transporter Cell Surface Expression and Vesicular Monoamine Transporter-2 Function in Rat Striatal Synaptosomes

Proteins Interacting with Monoamine Transporters: Current State and Future Challenges

(2011) Jonathan J. Sager et al.   BIOCHEMISTRY

Cocaine and HIV-1 Interplay: Molecular Mechanisms of Action and Addiction

(2011) Shilpa Buch et al.   Journal of Neuroimmune Pharmacology

The Substrate-Driven Transition to an Inward-Facing Conformation in the Functional Mechanism of the Dopamine Transporter

(2011) Jufang Shan et al.   PLoS One

fMRI brain activation during a delay discounting task in HIV-positive adults with and without cocaine dependence

(2011) Christina S. Meade et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Eradication of HIV from the brain: reasons for pause

(2010) Avindra Nath et al.   AIDS

Food Combination and Alzheimer Disease Risk

(2010) Yian Gu   ARCHIVES OF NEUROLOGY

Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses

(2010) C. Scheller et al.   JOURNAL OF NEURAL TRANSMISSION

Methamphetamine-Induced Behavioral and Physiological Effects in Adolescent and Adult HIV-1 Transgenic Rats

(2010) Marley D. Kass et al.   Journal of Neuroimmune Pharmacology

Human Immunodeficiency Virus-1 Tat Activates Calpain Proteases via the Ryanodine Receptor to Enhance Surface Dopamine Transporter Levels and Increase Transporter-Specific Uptake and Vmax

(2010) S. W. Perry et al.   JOURNAL OF NEUROSCIENCE

Preferential sensitivity of human dopaminergic neurons to gp120-induced oxidative damage

(2010) Shuxian Hu et al.   JOURNAL OF NEUROVIROLOGY

Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain

(2010) Susanna L Lamers et al.   JOURNAL OF NEUROVIROLOGY

Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance

(2010) Adarsh M. Kumar et al.   JOURNAL OF NEUROVIROLOGY

Declined neural efficiency in cognitively stable human immunodeficiency virus patients

(2009) Thomas Ernst et al.   ANNALS OF NEUROLOGY

Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens

(2009) Toni L. Richards et al.   JOURNAL OF NEUROCHEMISTRY

Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3

(2009) L. A. Egana et al.   JOURNAL OF NEUROSCIENCE

Dopamine and Amphetamine Rapidly Increase Dopamine Transporter Trafficking to the Surface: Live-Cell Imaging Using Total Internal Reflection Fluorescence Microscopy

(2009) C. A. Furman et al.   JOURNAL OF NEUROSCIENCE

Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains

(2009) Adarsh M Kumar et al.   JOURNAL OF NEUROVIROLOGY

HIV-1 Tat Protein-Induced Rapid and Reversible Decrease in [3H]Dopamine Uptake: Dissociation of [3H]Dopamine Uptake and [3H]2 -Carbomethoxy-3- -(4-fluorophenyl)tropane (WIN 35,428) Binding in Rat Striatal Synaptosomes

(2009) J. Zhu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Interplay between Cytosolic Dopamine, Calcium, and α-Synuclein Causes Selective Death of Substantia Nigra Neurons

(2009) Eugene V. Mosharov et al.   NEURON

Role of Tat Protein in HIV Neuropathogenesis

(2009) Wenxue Li et al.   NEUROTOXICITY RESEARCH

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

(2009) Grant R Campbell et al.   Retrovirology

Role of the Dopamine Transporter in the Action of Psychostimulants, Nicotine, and Other Drugs of Abuse

(2008) J. Zhu et al.   CNS & Neurological Disorders-Drug Targets

Nicotinic Receptor Activation Increases [3H]Dopamine Uptake and Cell Surface Expression of Dopamine Transporters in Rat Prefrontal Cortex

(2008) J. Zhu et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse

(2008) Linda Chang et al.   NEUROIMAGE

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

(2008) Annette E. Fleckenstein et al.   NEUROPHARMACOLOGY

Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: Current status of dopamine system vulnerability in NeuroAIDS

(2008) Mark J. Ferris et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent

(2007) Ekaterina Boudanova et al.   NEUROPHARMACOLOGY